After 30 months of fast-paced innovation in quantum algorithms, six research groups are hoping to hit paydirt. But there can be only one big winner—if there is a winner at all.

A new synthesis finds that common epilepsies are driven by thousands of tiny-effect genetic variants, most still ...

AI is only as good as the data it learns from. Right now, research suggests 73% of health data in AI comes from North America, South America and Europe. But those regions only make up around 22% of ...

An insightful mini-review published in Genomic Psychiatry synthesizes the rapidly expanding landscape of molecular genetic research on common epilepsies, assembling evidence from genome-wide ...

Since Hardy was writing in 1940, there was a touch of the humblebrag about this claim. Chemist Fritz Haber had created ...

Transforming a nation of 1.4 billion people into the world's leading R&D hub is a monumental task. But by liberating the minds of the next generation of Indian scientists at 11, 12, and 13 years old, ...

Discover how AI healthcare technology and machine learning diagnosis are transforming disease detection, improving accuracy, and reshaping patient care in today's evolving medical landscape.

Researchers combined AI simulations with NMR data to capture fleeting structures of intrinsically disordered proteins, ...

Navigating the Future of Cancer Diagnostics and Liquid BiopsyThe global healthcare landscape is witnessing a massive shift toward precision medicine. At the heart of this revolution lies the study of ...